Chemed Co. (CHE) Shares Bought by Great West Life Assurance Co. Can

Great West Life Assurance Co. Can increased its holdings in Chemed Co. (NYSE:CHE) by 37.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,694 shares of the company’s stock after acquiring an additional 5,070 shares during the period. Great West Life Assurance Co. Can owned about 0.12% of Chemed worth $5,100,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in the stock. Bremer Trust National Association purchased a new stake in shares of Chemed during the 4th quarter worth about $25,000. Financial Gravity Companies Inc. purchased a new stake in shares of Chemed during the 4th quarter worth about $45,000. First Hawaiian Bank raised its stake in shares of Chemed by 21.3% during the 4th quarter. First Hawaiian Bank now owns 290 shares of the company’s stock worth $82,000 after purchasing an additional 51 shares in the last quarter. Enlightenment Research LLC purchased a new stake in shares of Chemed during the 4th quarter worth about $85,000. Finally, Franklin Resources Inc. purchased a new stake in shares of Chemed during the 3rd quarter worth about $225,000. 87.06% of the stock is owned by hedge funds and other institutional investors.

CHE opened at $326.38 on Friday. Chemed Co. has a fifty-two week low of $260.03 and a fifty-two week high of $335.99. The company has a debt-to-equity ratio of 0.15, a current ratio of 0.83 and a quick ratio of 0.80. The stock has a market cap of $5.21 billion, a PE ratio of 27.36, a PEG ratio of 1.85 and a beta of 1.21.

Chemed (NYSE:CHE) last posted its quarterly earnings results on Wednesday, February 20th. The company reported $3.35 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.27 by $0.08. Chemed had a return on equity of 36.06% and a net margin of 11.53%. The company had revenue of $457.51 million during the quarter, compared to the consensus estimate of $460.50 million. During the same period last year, the business earned $2.32 EPS. The business’s quarterly revenue was up 6.8% on a year-over-year basis. On average, research analysts forecast that Chemed Co. will post 12.77 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, March 22nd. Stockholders of record on Monday, March 4th will be paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 0.37%. The ex-dividend date is Friday, March 1st. Chemed’s dividend payout ratio (DPR) is presently 10.06%.

A number of equities research analysts have recently weighed in on CHE shares. Zacks Investment Research downgraded Chemed from a “buy” rating to a “hold” rating in a research note on Wednesday, January 2nd. Royal Bank of Canada raised their price target on Chemed from $313.00 to $318.00 and gave the stock a “sector perform” rating in a research note on Monday, February 25th.

In other news, CEO Kevin J. Mcnamara sold 5,000 shares of the stock in a transaction dated Tuesday, February 26th. The stock was sold at an average price of $323.47, for a total transaction of $1,617,350.00. Following the transaction, the chief executive officer now owns 155,094 shares of the company’s stock, valued at approximately $50,168,256.18. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Thomas P. Rice sold 2,000 shares of the stock in a transaction dated Wednesday, February 27th. The shares were sold at an average price of $327.67, for a total value of $655,340.00. Following the transaction, the director now directly owns 5,582 shares in the company, valued at approximately $1,829,053.94. The disclosure for this sale can be found here. Over the last ninety days, insiders have bought 36 shares of company stock valued at $8,599 and have sold 13,199 shares valued at $4,300,053. 4.82% of the stock is owned by company insiders.

COPYRIGHT VIOLATION WARNING: This news story was originally published by American Banking News and is owned by of American Banking News. If you are accessing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2019/03/17/chemed-co-che-shares-bought-by-great-west-life-assurance-co-can.html.

About Chemed

Chemed Corporation provides hospice and palliative care services in the United States. It operates through two segments, VITAS and Roto-Rooter. The VITAS segment offers direct medical services, as well as spiritual and emotional counseling services to terminally ill patients. This segment offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers.

Featured Article: Asset Allocation and Your Retirement

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply